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The EPIC trial demonstrated the potent platelet IIbl1l1a inhibitor. c7E3 reduced
the incidence of acute complications in high risk angioplasty. The primary
endpoint was a composite of death. myocardial infarction (MI), repeat ur-
gent PTCA or CABG. and emergency stent or balloon pump insertion. Event
rates were recorded by the first occurrence of an endpoint, yet 30% of pts
experienced more than one endpoint. To further characterize the mecha-
nism of effect of potent platelet antagonism during angioplasty. we deter-
mined c7E3's efficacy according to the most serious endpoint reached. End-
points were ranked hierarchically according to degree of seriousness in the
order of death, MI, and urgent intervention. The three treatment groups were
placebo, bolus (B) or bolus plus infusion (B + I) of c7E3.
Results: There were no differences in death rates among the 3 treatment
groups, (although 2 pts who died in the B + I group never received the drug).
Reduction in MI in pts who survived (4.4% B + Ivs 7.9% placebo), accounted
for 78% of the 4.5% absolute decrease in the composite primary endpoint
by B + I (8.3% vs 12.8% placebo p = 0.003). In pts that survived and had
no MI, a reduction in urgent repeat intervention (2.2% vs 3.2% for placebo)
accounted for only 22% of the overall reduction of the primary endpoint by
B + I. Although urgent repeat intervention was less with B + I, the greatest
benefit was in pts who also had MI (1.4% vs 4.5% in placebo p < 0.001).
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Conclusions: Hierarchical endpoint analysis demonstrates that the mecha-
nism of benefit of c7E3 bolus plus infusion treatment in high risk angioplasty
was principally the reduction of MI, ratherthan a decrease in need for urgent
repeat intervention.
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Mechanism of Benefit of Platelet lib/ilia Receptor
Inhibition in High Risk Angioplasty in the EPIC Trial:
A Hierarchical Endpoint Analysis
Jeffrey Lefkovlts, Keaven Anderson. Harlan Weisman. Eric J, Topol, EPIC
Investigators. Cleveland Clinic, Cleveland, OH
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James Benard, Patrick Mauldin, Edmund Becker, Spencer B. King III. Emory
University School of Medicine, Allanta, GA
While in recent years there has been concern with the cost of interventional
cardiology, technical improvements that may have impact to lower resource
utilization. Thus, the results of and indices of resource utilization of interven-
tional procedures in 17.263 patients from 1980 through 1993 were reviewed.
Previous studies have shown emergency surgery (CABG) and length of stay
(LOS) to be the strongest correlates of cost (r = 0.89). Results (mean or %.
MV ~ multivessel, EF = ejection fraction, New Dev = new devices, Ang
Suc = angiographic success, Q MI = Q wave myocardial infarction. BID =
number of balloons or devices, LOS in days):
reference segments. These findings have potentially important implications
for the clinical approach to intervention.
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Reference Pmin Pmax Parea CSAred
Segments (mm) (mm) Imm2) (%)
HCY <8 J,Lmol/L 0.18 076 438 32.3%
HCY >8 J,Lmol/L 0.27 1.04 6.98 40.3%
P value <0.0005 <0,0001 <0.0001 <0,0012
ministered as non-weight adjusted bolus doses to a therapeutic activated
clotting time (ACT): bleeding increased with maximal in-lab ACT and relative
heparin dose. To evaluate the safety and efficacy of weight-adjusted heparin
dosing during c7E3 administration (0.25 mglkg bolus, 10 mcglmin infusion
x 12 hrs). 103 pts undergoing coronary intervention were randomized to 1
of 2 regimens of heparin in a blinded fashion: 100 Ulkg bolus + additional
doses to achieve ACT> 300 sec (Standard Dose, n = 51), or 70 Ulkg bolus
without ACT adjustment (Low Dose, n = 52). ACT values immediately prior
to intervention (median and interquartile range) and bleeding complications
(unrelated to CABG) during the first 36 hrs (compared to 708 EPIC pts re-
ceiving same c7E3 dose). femoral hematoma >5 cm in size, and in-hospital
death or MI were:
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Low Plasma Homocysteine Levels Predict Reduced
Atheroma Burden in Patients Undergoing Coronary
Interventions: Evidence from Intravascular
Ultrasound
Ellen L. Mayer. Killian Robinson. Donald W. Jacobsen. E. Murat Tuzcu. Anthony
C. De Franco. David J. Moliterno, Skip Guyer. Steven E. Nissen. Cleveland Clinic
Foundation, Cleveland, OH
Thus, reduced weight-adjusted heparin dosing with c7E3 antiplatelet ther-
apy during coronary intervention in this pilot study did not increase ischemic
events, and at the same time appeared to decrease bleeding complications.
Weight-adjusted heparin strategies will be further tested in a large-scale, ran-
domized trial (EPILOG).
Objectives: Elevated plasma homocysteine (HCYI is an important risk factor
for premature coronary atherosclerosis. Intravascular ultrasound commonly
demonstrates extensive plaque burden at "normal" reference sites in inter-
ventional patients, averaging 38% area reduction. We performed this study
to determine if HCY levels predict which patients exhibit diffuse disease in-
volving reference segments.
Methods: We measured plasma homocysteine (J,LmoIlU in 62 patients
undergoing coronary interventions. Intravascular ultrasound was performed
with a 30 MHz, 3,5 F probe, examining both target lesions and reference
segments. A blinded core laboratory quantified four measures of atheroma
burden - maximum and minimum plaque thickness IPmin and Pmax ) respec-
tively, plaque cross-sectional area (Parea), and percentage cross-sectional
area reduction (CSAred)'
Results: Measures of atheroma extent and distribution at target lesions
were similar in both groups. However, at reference segments:
Strong statistical significance for a protective effect of a low homocys-
teine level persisted when controlling for age, gender, diabetes, hyperten-
sion, cholesterol and smoking in the two cohorts.
Conclusions: In interventional patients, low plasma homocysteine levels
independently predict the presence of focal atherosclerosis with sparing of
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Year 80-2 83-4 85-6 87-8 89-0 91-2 93 P
n 1272 2435 2602 2879 3283 3416 1376
Age 54 56 58 59 60 61 62 <0.0001
MV(%) 16 20 36 43 48 52 53 <0.0001
EF 63 61 56 58 55 55 54 <0.0001
NewDev(%1 a a a 0.6 7.3 16 15 <0.0001
B/D 202 (%) 7 12 16 12 12 <0.0001
Ang Sue (%1 86 91 84 84 90 93 93 <0.0001
Death (%) 0.1 03 07 09 07 07 07 0.018
OMI(%) 23 2.4 2.4 19 0.9 09 10 <0.0001
CABG(%} 10 53 69 60 39 31 30 <0.0001
LOS >2% (%) 15 15 20 19 15 12 4 <0.0001
Patients undergoing procedures continue to get older and sicker. Nonethe-
less, success rates continue to improve, and complication rates fall. Mortal-
ity is unchanged since 1985 despites sicker patients, Device usage has been
constant since 1991 and the number of balloons/devices per case is falling,
From a resource standpoint. the most important indices of emergent CABG
and prolonged LOS are decreasing. Intervention in the coronaries can be
safely performed while steps are taken to minimize cost.
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1712-1 1 Intraoperative Transesophageal Echocardiography
Under-Estimates the Severity of Functional Mitral
Regurgitation
David S, Bach, Carolyn L. Donovan, Louis A. Brunsting, G, Michael Deeb, Steven
F. Bolling. University of Michigan. Ann Arbor. MI
Although intraoperative transesophageal echocardiography ITEE) has been
used to guide the need for valve reconstruction in patients with mitral regur-
gitation (MR). the effects of hemodynamic alterations accompanying general
anesthesia on MR jet size are unknown, This study was undertaken to com-
pare MR jet size before and after the induction of general anesthesia, 46
of 133 patients undergoing mitral valve surgery between 11/92 and 4/94 had
TEE performed both preoperatively under IV conscious sedation (preOp) and
intraoperatively following induction of general anesthesia (IntraOp), 21 of 46
patients (46%) had degenerative mitral disease with leaflet flail (Flail) and 25
(54%) had functional MR as a result of annular dilation (Functional). The width
of the MR jet at its vena contracta (Width) and the maximal jet area (Area)
were determined for each patient on both PreOp and IntraOp TEE, Doppler
Nyquist limits for paired studies were similar. Systolic blood pressure (SBP)
and pressure rate product (PRP) at the time of MR jet measurements were
available for 33 patients (72%),
Flail Functional
PreOp IntraOp PreOp IntraOp
SBPlmmHg) 116 ± 17 123 ± 17 108 ± 17 120 ± 19t
PRP x 100 103 ± 97 97 ± 22 t 95 ± 22 97 ± 23t
Width (mm) 1.1 ± 0,3 1,0 ± 0,3 t 1.0 ± 03 0.7 ± 0.3"
Area (cm2) 10.1 ± 5.2 9,8 ± 4,5 t 9,0 ± 4.3 5.4 ± 3.9"
t P ~ NS VS, PreOp " p < 0,001 vs, PreOp
We conclude that 1) MR related to leaflet flail is adequately quantified on
IntraOp TEE, whereas 2) the severity of functional MR may be significantly
underestimated in patients under general anesthesia, Alteration of systemic
vascular resistance independent of blood pressure may be responsible for
this observation, Patients with functional MR in whom mitral surgery is con-
sidered should undergo imaging for MR quantification prior to the induction
of general anesthesia,
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1712-21 Comparison of Transesophageal Echocardiographic
and Surgical Assessment of Mitral Regurgitant
Lesions: Accuracy and Incremental Value
Maurice E, Sarano, James B. Seward, A, Jamll TaJik, Mayo Clinic, Rochester. MN
Transesophageal echocardiographic (TEE) provides superb images of the mi-
tral valve, In patients with mitral regurgitation (MR) the type of lesion condi-
tions the ability to perform a valve repair, suggesting liberal indications of
TEE preoperatively, However, the accuracy of TEE and its incremental value
over transthoracic echocardiography(TIE) are not available to determine the
proper utilization of resources. Among 347 patients operated on between
1988 and 1991 for pure, isolated MR, 248 had a preoperative TEE (age =
64 ± 14 years, 152 males) and 216 of them had a preoperative TIE, The
accuracy (Ac) of HE and TEE, the percentage of patients with incremental
accuracy of TEE (% Inc) and the percentage of TIE errors corrected by TEE
(% Corr) were:
Ace TEE Ace TTE P % Inc %Corr
Etiology 99% 95% 0.008 3.7% 80%
Mechanism 99% 94% 0,002 4.6% 77%
Vegetations 99% 95% 0008 3.7% 73%
Prolapse 93% 80% 0001 13.9% 70%
Flail segment 96% 80% 0.001 16.2% 81%
Rupture chord 87% 57% 0.001 32.4% 75%
The % Inc was significantly higher when the anatomy was felt to be in-
completely described by the observer (vegetations 15% vs 1%, P = 0.0001,
prolapse 36% vs 9%, P = 0.0001 I.
In conclusion, 1)the high resolution imaging of TEE allows a high accuracy
of anatomic assessment but. 2)the incremental value over TIE is moderate
and most significant for ruptured chordae or when TIE is incomplete and
thus, 3)TEE should be performed preoperatively in selected cases in which
the probability for incremental value is high.
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1712-31 Predictive Value of Intraoperative Transesophageal
Color Doppler Flow Imaging During Mitral Valve
Repair
Irene M. Hellemans, Els G. Pieper, Johannes P.M. Hamer. Wybren Jaarsma. Renee
B.A. van den Brink, Kees B. Prenger, Patricia F.A. Bakker, Eric Berreklouw, Jan
G.P. Tijssen, Cees A. Visser, ESMIR study group (Echocardiographic Selection of
patients for Mitral valve Repair). Interuniversity Cardiology Institute (IClN), Utrecht,
The Netherlands
To assess the predictive value of Residual Mitral Regurgitation (RMR) af-
ter valve repair for severe MR, we performed transesophageal color (TEE)
Doppler flow imaging intraoperatively, after 3 months and 1 year at similar
loading conditions in a prospective study of 178 patients Ipts). Intraopera-
tive grading of RMR on a 4 point scale in 159 pts showed no RMR in 77 pts,
grade I in 45, grade II in 29 and grade III in 8 pts.
Univariate analysis of preoperative and surgical characteristics showed
that a history of chronic lung disease (Relative Risk (RR) 1.88"), increased
leaflet mobility(RR 1.50") and normal leaflet mobility (RR 1.51*) at TEE, coro-
nary artery disease (RR 1.38), and a Duran annular ring (RR 1.97*) were as-
sociated with an increased risk of intraoperative RMR.
In the 8 pts with grade III RMR, immediate valve replacement (VR) was
advised and performed in all but one pt. who underwent VR 2 months later.
After 3 months, increase of RMR lof at least one grade) was present in
63%, reduction in 8% and no change in 29% of the pts. Compared to three
months, no increase or decrease of RMR was seen at 1 year
During the one year follow-up VR was performed in another 7 pts; all but
one pt (no RMR) with intraoperative RMR grade I-II. Intraoperative RMR
Igrade I-II) was associated with a higher risk of VR (RR 6.51") and throm-
boembolic events (RR 6.51") in relation to absence of RMR, during this one
year follow-up.
Conclusions: (1) RMR increases in most pts within 3 months postopera-
tively and is stable thereafter. (2) Intraoperative RMR is associated with a
substantial reoperation rate and risk of thromboembolic events. 131 RMR S
grade II does not exclude a redo during one year follow-up.
• = P < 0.05.
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1712-41 Role of Intraoperative Transesophageal
Echocardiography in Patients with Hypertrophic
Obstructive Cardiomyopathy
Seong H. Park, Roger L. Click, William K. Freeman, Jae K. Oh, Hartzell V. Schaff,
Gordon K. Danielson, Donald J. Hagler, A. Jamil Tajik. James B. Seward. Mayo
Clinic, Rochester; Minnesota
To evaluate the role of intraoperative TEE (IOTEE) in hypertrophic obstructive
cardiomyopathy (HOCM), IOTEE in 74 patients with HOCM who underwent
myectomy from 1988 to 1993 were reviewed. There were 38 men and 36
women with a mean age of 45 ± 22 years (range: 2-821. All had preoper-
ative transthoracic echo showing dynamic LVOT obstruction with a mean
peak gradient of 73 ± 37 mmHg and a basal septal thickness of 25 ± 9
mm at baseline. Prior to cardiopulmonary bypass, IOTEE discovered unsus-
pected morphologic abnormalities in 9 (12%): subaortic membrane 1, flail
mitral valve 1, tricuspid valve fibroelastoma 1, mitral valve prolapse 4, patent
